Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

(2020) Charles E. Evans et al.   ACTA NEUROPATHOLOGICA

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

(2020) Muthiah Vaduganathan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Getting to the Heart of Alzheimer Disease

(2019) Joshua M. Tublin et al.   CIRCULATION RESEARCH

Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats

(2019) Henning J. Drews et al.   Neurotherapeutics

Observational Study of Brain Atrophy and Cognitive Decline Comparing a Sample of Community-Dwelling People Taking Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Over Time

(2019) Chris Moran et al.   JOURNAL OF ALZHEIMERS DISEASE

Synergism between fornix microstructure and beta-amyloid accelerates memory decline in clinically normal older adults

(2019) Jennifer S. Rabin et al.   NEUROBIOLOGY OF AGING

Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer’s disease

(2019) Noura S. AL Mulhim et al.   Acta Neuropathologica Communications

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study

(2019) Venexia M Walker et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

The Relationship Between the Use of Antihypertensive Drugs and the Incidence of Dementia in General Practices in Germany

(2019) Jens Bohlken et al.   JOURNAL OF ALZHEIMERS DISEASE

Reciprocal predictive relationships between amyloid and tau biomarkers in Alzheimer's disease progression; an empirical model

(2019) Saffire Hanna Krance et al.   JOURNAL OF NEUROSCIENCE

Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography

(2019) Niklas Mattsson et al.   JAMA Neurology

Counter-regulatory renin–angiotensin system in cardiovascular disease

(2019) Maria Paz Ocaranza et al.   Nature Reviews Cardiology

Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies

(2019) Jie Ding et al.   LANCET NEUROLOGY

Investigation of antihypertensive class, dementia, and cognitive decline

(2019) Ruth Peters et al.   NEUROLOGY

Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia

(2018) Fabricio Ferreira de Oliveira et al.   Current Alzheimer Research

The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?

(2018) Patrick Gavin Kehoe   JOURNAL OF ALZHEIMERS DISEASE

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

(2018) Brian Lawlor et al.   PLOS MEDICINE

Vascular Risk and β -Amyloid Are Synergistically Associated with Cortical Tau

(2018) Jennifer S. Rabin et al.   ANNALS OF NEUROLOGY

The association of multiple anti-hypertensive medication classes with Alzheimer’s disease incidence across sex, race, and ethnicity

(2018) Douglas Barthold et al.   PLoS One

Polygenic hazard score, amyloid deposition and Alzheimer’s neurodegeneration

(2018) Chin Hong Tan et al.   BRAIN

Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study

(2017) Jodi D. Edwards et al.   JOURNAL OF ALZHEIMERS DISEASE

Dementia prevention, intervention, and care

(2017) Gill Livingston et al.   LANCET

In vivo staging of regional amyloid deposition

(2017) Michel J. Grothe et al.   NEUROLOGY

ApoE4 Accelerates Early Seeding of Amyloid Pathology

(2017) Chia-Chen Liu et al.   NEURON

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

(2017) Sebastian Palmqvist et al.   Nature Communications

Association between Antihypertensive Drug Use and the Incidence of Cognitive Decline and Dementia: A Meta-Analysis of Prospective Cohort Studies

(2017) Guangli Xu et al.   Biomed Research International

Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function

(2016) Amanda M. Di Battista et al.   Current Alzheimer Research

Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention

(2016) Daniel A. Nation et al.   JOURNAL OF ALZHEIMERS DISEASE

Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex

(2016) Emma L. Ashby et al.   JOURNAL OF ALZHEIMERS DISEASE

Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink

(2015) Kah L. Goh et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Measurement of Longitudinal  -Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios

(2015) S. M. Landau et al.   JOURNAL OF NUCLEAR MEDICINE

Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker

(2014) M. Furuhashi et al.   AMERICAN JOURNAL OF HYPERTENSION

Angiotensin Converting Enzyme Inhibitors and Alzheimer Disease in the Presence of the Apolipoprotein E4 Allele

(2013) Wendy Wei Qiao Qiu et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

(2013) Victor L Villemagne et al.   LANCET NEUROLOGY

Antihypertensive medication use and risk of cognitive impairment: The Honolulu-Asia Aging Study

(2013) R. P. Gelber et al.   NEUROLOGY

Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study

(2013) S. Yasar et al.   NEUROLOGY

Brain  -amyloid load approaches a plateau

(2013) C. R. Jack et al.   NEUROLOGY

ApoE influences amyloid-  (A ) clearance despite minimal apoE/A  association in physiological conditions

(2013) P. B. Verghese et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer’s Disease

(2013) Marcus O. W. Grimm et al.   Frontiers in Aging Neuroscience

Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series

(2012) Ihab Hajjar et al.   ARCHIVES OF NEUROLOGY

Hypertension Induces Brain β-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature

(2012) Daniela Carnevale et al.   HYPERTENSION

Amyloid-  Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods

(2012) S. M. Landau et al.   JOURNAL OF NUCLEAR MEDICINE

Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease

(2010) Lusine Danielyan et al.   REJUVENATION RESEARCH

Effects of Antihypertensive Therapy on Cognitive Decline in Alzheimer's Disease

(2009) E. Duron et al.   AMERICAN JOURNAL OF HYPERTENSION

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors

(2009) Albert Fournier et al.   Expert Review of Neurotherapeutics

Angiotensin Receptor Blocker Prevented β-Amyloid-Induced Cognitive Impairment Associated With Recovery of Neurovascular Coupling

(2009) Shuko Takeda et al.   HYPERTENSION

Review: Blood pressure and dementia — a comprehensive review

(2009) Sean P. Kennelly et al.   Therapeutic Advances in Neurological Disorders

Telmisartan prevented cognitive decline partly due to PPAR-γ activation

(2008) Masaki Mogi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS